DMXU Among Developed ETFs
End-of-day Nov 17, 2026 · 66 Developed ETFs by 1W
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.3% | −2.9% | −2.7% | −7.7% | +3.6% | +7.1% | +45.7% | +30.2% | — | +88.8% |
| Peer average | −1.0% | −2.2% | −1.3% | −4.6% | +8.1% | +11.0% | +62.3% | +47.9% | +145.8% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$27 of every $1,000 in DMXU is Samsung
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 005930.KSSamsung Electronics | Technology | 2.74% | $273.95 | 11K | $1.6M |
| 2 | ASML.ASAsml | Technology | 2.16% | $215.93 | 885 | $1.3M |
| 3 | 000660.KSSK Hynix | Technology | 1.65% | $165.42 | 1,163 | $975K |
| 4 | ROP.SWRoche AG Part | Healthcare | 1.36% | $135.80 | 1,641 | $800K |
| 5 | —Cash & Cash Equivalents | — | 1.34% | $134.49 | 0 | $793K |
| 6 | NOVN.SWNovartis AG-Reg | Healthcare | 1.21% | $120.55 | 4,392 | $711K |
| 7 | HSBA.LHsbc | Financial Services | 1.21% | $120.54 | 40K | $710K |
| 8 | SHEL.LShell | Energy | 1.12% | $112.03 | 14K | $660K |
| 9 | AZN.LAstraZeneca | Healthcare | 1.10% | $109.70 | 3,494 | $647K |
| 10 | NESN.SWNestle -Reg | Consumer Defensive | 1.07% | $106.86 | 5,998 | $630K |
| 11 | RY.TORoyal Bank of Canada | Financial Services | 1.03% | $102.90 | 3,037 | $606K |
| 12 | SAP.DESAP SE | Technology | 0.90% | $90.38 | 2,268 | $533K |
| 13 | SIE.DESiemens AG-Reg | Industrials | 0.90% | $90.34 | 1,775 | $532K |
| 14 | 8306.TMitsubishi UFJ Financial Group | Financial Services | 0.84% | $84.24 | 23K | $496K |
| 15 | ALV.DEAllianz SE-Reg | Financial Services | 0.79% | $78.62 | 886 | $463K |
of the $687B in 67 Developed ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 005930.KS | Samsung Electronics | 2.74% |
| 2 | ASML.AS | Asml | 2.16% |
| 3 | 000660.KS | SK Hynix | 1.65% |
| 4 | ROP.SW | Roche AG Part | 1.36% |
| 5 | NOVN.SW | Novartis AG-Reg | 1.21% |
| 6 | HSBA.L | Hsbc | 1.21% |
| 7 | SHEL.L | Shell | 1.12% |
| 8 | AZN.L | AstraZeneca | 1.10% |
| 9 | NESN.SW | Nestle -Reg | 1.07% |
| 10 | RY.TO | Royal Bank of Canada | 1.03% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 18, 2026 | Jun 26, 2026 | $0.56 |
| Dec 19, 2025 | Dec 29, 2025 | $0.91 |
| Jun 20, 2025 | Jun 27, 2025 | $0.56 |
| Dec 20, 2024 | Dec 30, 2024 | $0.34 |
| Jun 21, 2024 | Jun 28, 2024 | $0.52 |
| Dec 15, 2023 | Dec 22, 2023 | $0.26 |
| Jun 23, 2023 | Jun 30, 2023 | $0.48 |
| Dec 16, 2022 | Dec 23, 2022 | $0.21 |
| Jun 24, 2022 | Jul 1, 2022 | $0.42 |
| Dec 17, 2021 | Dec 27, 2021 | $0.39 |
| Jun 25, 2021 | Jul 2, 2021 | $0.46 |
| Dec 18, 2020 | Dec 28, 2020 | $0.23 |